Effectiveness of Physical Exercise in Older Adults With Mild to Moderate Depression.
Hidalgo JL, Sotos JR; DEP-EXERCISE Group.
Ann Fam Med. 2021 Jul-Aug;19(4):302-309. doi: 10.1370/afm.2670.
Depression.
Rakel RE.
Prim Care. 1999 Jun;26(2):211-24. doi: 10.1016/s0095-4543(08)70003-4.
Effectiveness of physical exercise in the treatment of depression in older adults as an alternative to antidepressant drugs in primary care.
López-Torres Hidalgo J; DEP-EXERCISE Group.
BMC Psychiatry. 2019 Jan 14;19(1):21. doi: 10.1186/s12888-018-1982-6.
Neurobiology of emotional trauma.
Giotakos O.
Psychiatriki. 2020 Apr-Jun;31(2):162-171. doi: 10.22365/jpsych.2020.312.162.
Enhancing Recovery From Sepsis: A Review.
Prescott HC, Angus DC.
JAMA. 2018 Jan 2;319(1):62-75. doi: 10.1001/jama.2017.17687.
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies.
Solmi M, De Toffol M, Kim JY, Choi MJ, Stubbs B, Thompson T, Firth J, Miola A, Croatto G, Baggio F, Michelon S, Ballan L, Gerdle B, Monaco F, Simonato P, Scocco P, Ricca V, Castellini G, Fornaro M, Murru A, Vieta E, Fusar-Poli P, Barbui C, Ioannidis JPA, Carvalho AF, Radua J, Correll CU, Cortese S, Murray RM, Castle D, Shin JI, Dragioti E.
BMJ. 2023 Aug 30;382:e072348. doi: 10.1136/bmj-2022-072348.
Identifying risk factors for first-episode neck pain: A systematic review.
Kim R, Wiest C, Clark K, Cook C, Horn M.
Musculoskelet Sci Pract. 2018 Feb;33:77-83. doi: 10.1016/j.msksp.2017.11.007. Epub 2017 Nov 22.
Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment.
Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D.
Eur J Pain. 2006 May;10(4):287-333. doi: 10.1016/j.ejpain.2005.06.009. Epub 2005 Aug 10.
Depression in the medically ill.
Rosenblat JD, Kurdyak P, Cosci F, Berk M, Maes M, Brunoni AR, Li M, Rodin G, McIntyre RS, Carvalho AF.
Aust N Z J Psychiatry. 2020 Apr;54(4):346-366. doi: 10.1177/0004867419888576. Epub 2019 Nov 21.
Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study.
Schmidt ME, Kezic I, Popova V, Melkote R, Van Der Ark P, Pemberton DJ, Mareels G, Canuso CM, Fava M, Drevets WC.
Neuropsychopharmacology. 2024 Aug;49(9):1437-1447. doi: 10.1038/s41386-024-01862-x. Epub 2024 Apr 22.
